rs118192171
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PS1PM1PM5PP2PP3PP5_Moderate
The NM_000540.3(RYR1):c.14761_14762delinsAC(p.Phe4921Thr) variant causes a missense change involving the alteration of a conserved nucleotide. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in same amino acid change has been previously reported as Pathogenicin Lovd. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F4921L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000540.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RYR1 | NM_000540.3 | c.14761_14762delinsAC | p.Phe4921Thr | missense_variant | 102/106 | ENST00000359596.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RYR1 | ENST00000359596.8 | c.14761_14762delinsAC | p.Phe4921Thr | missense_variant | 102/106 | 5 | NM_000540.3 | A2 |
Frequencies
GnomAD3 genomes ? Cov.: 29
GnomAD4 genome ? Cov.: 29
ClinVar
Submissions by phenotype
Central core myopathy Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 08, 2008 | - - |
Neuromuscular disease, congenital, with uniform type 1 fiber Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 08, 2008 | - - |
RYR1-Related Disorders Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Invitae | Mar 22, 2023 | Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Phe4921 amino acid residue in RYR1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16621918; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 12995). This missense change has been observed in individual(s) with clinical features of autosomal dominant central core disease (PMID: 16621918, 32381727; Invitae). In at least one individual the variant was observed to be de novo. Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. This sequence change replaces phenylalanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 4921 of the RYR1 protein (p.Phe4921Thr). - |
not provided Other:1
not provided, no classification provided | literature only | Leiden Muscular Dystrophy (RYR1) | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at